| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.9 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |